Assess the economic burden, impact on patients/caregivers, and unmet needs associated with AD Describe the value of early AD diagnosis and treatment Evaluate the efficacy/safety data and administration considerations of available/emerging amyloid-beta targeting therapies for early AD Apply evidence-based guidelines and recommendations for the timely identification, mitigation, and management of adverse events associated with amyloid-beta targeting therapies Implement managed care strategies to balance treatment efficacy and best practices with cost-effectiveness for optimal outcomes in patients with AD
- Provider:HMP Education
- Activity Link: https://hmpeducation.com/program/24mclncme3031
- Start Date: 2024-11-16 06:00:00
- End Date: 2024-11-16 06:00:00
- Credit Details: AAPA Category 1 Credit™️: 1.5 hours
AMA PRA Category 1 Credit™️: 1.5 hours
Nursing: 1.5 hours
Pharmacy: 1.5 hours - MOC Credit Details: ABS - 1.5 Point; Credit Type(s): Accredited CME (ABS)
- Commercial Support: Source: Lilly (Any division) - Amount: 0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: General Surgery
Subscribe
Login
0 Comments
Oldest